Related Experiment Video
Updated: Sep 7, 2025

Surgical Treatment of an Endolymphatic Sac Tumor
Published on: May 26, 2023
Concurrent intraventricular intracranial myxoid mesenchymal tumor and ependymoma in a long-term Ewing sarcoma
Adam S Levy1, Ana Sakellakis1, Evan Luther1
1Department of Neurosurgery, University of Miami Miller School of Medicine, Miami, Florida, USA.
Abstract:
Intracranial myxoid mesenchymal tumor, FET::CREB fusion positive is a rare, recently described central nervous system neoplasm. It is characterized by EWSR1::CREB family transcription factor fusion, typically arises in children and adolescents, and is locally aggressive even after gross total resection. Currently, there are little data available to guide management and gauge long-term prognosis. Furthermore, there have been no reports of these lesions occurring simultaneously with other intracranial neoplasms or in patients with a history of malignancy. Here we describe the first case of a very unusual patient with intracranial myxoid mesenchymal tumor of the right lateral ventricle with a concurrent fourth ventricular ependymoma who had a remote history of Ewing sarcoma of the right fibula.

